Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000667567 | SCV000792041 | uncertain significance | Metachromatic leukodystrophy | 2017-06-08 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000667567 | SCV002291102 | pathogenic | Metachromatic leukodystrophy | 2024-08-17 | criteria provided, single submitter | clinical testing | This sequence change falls in intron 6 of the ARSA gene. It does not directly change the encoded amino acid sequence of the ARSA protein. RNA analysis indicates that this variant induces altered splicing and may result in an absent or altered protein product. This variant is present in population databases (no rsID available, gnomAD 0.0009%). This variant has been observed in individual(s) with metachromatic leukodystrophy (PMID: 18693274, 26462614, 31922725). This variant is also known as c.1102-3C>G. ClinVar contains an entry for this variant (Variation ID: 552329). Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Studies have shown that this variant results in skipping of exon 7 and activation of a cryptic splice site, and produces a non-functional protein and/or introduces a premature termination codon (Invitae). For these reasons, this variant has been classified as Pathogenic. |
Fulgent Genetics, |
RCV000667567 | SCV005656798 | pathogenic | Metachromatic leukodystrophy | 2024-05-23 | criteria provided, single submitter | clinical testing | |
Gelb Laboratory, |
RCV000667567 | SCV005046718 | not provided | Metachromatic leukodystrophy | no assertion provided | in vitro |